Duodenal and rectal mucosal microbiota related to small intestinal bacterial overgrowth in diarrhea-predominant irritable bowel syndromeOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study looked for a mucosal microbiota pattern tied to small intestinal bacterial overgrowth in diarrhea-predominant irritable bowel syndrome. Researchers compared patients with and without overgrowth. Overgrowth was diagnosed by a standard glucose hydrogen breath test. Samples of duodenal mucosa, duodenal fluid, rectal mucosa, and fresh feces underwent 16S rRNA gene sequencing. The team assessed alpha and beta diversity plus microbial composition and predicted function across these four sample types.
Who was studied?
Subjects were adults with diarrhea-predominant irritable bowel syndrome meeting Rome III criteria. This was a human clinical study across a wide adult age range. Patients were split into an exploratory cohort of 57 cases and a validation cohort of 20 cases. They were classified by presence or absence of small intestinal bacterial overgrowth. Samples spanned both the small intestine and the rectum, comparing mucosal tissue against luminal fluid and stool.
What were the most important findings?
Microbial diversity and composition differed clearly between overgrowth and non-overgrowth patients in duodenal and rectal mucosa, but not in duodenal fluid or feces. The signal was in the mucosa, not the lumen. Rectal mucosa in overgrowth cases showed reduced aerobic and Gram-negative bacteria and increased facultative anaerobic and Gram-positive bacteria, with altered metabolic function. A rectal mucosa dysbiosis index cutoff of -0.37 identified overgrowth with 56.55 percent sensitivity and 90.91 percent specificity.
What are the greatest implications of this study?
Mucosa-associated microbiota show clearer dysbiosis than luminal bacteria in these patients. This suggests mucosal sampling captures overgrowth-related changes that stool testing may miss. Rectal mucosal microbiota might serve as a predictor of small intestinal bacterial overgrowth in this subtype of irritable bowel syndrome. The modest sensitivity and single-center design mean the dysbiosis index needs validation before clinical use as a diagnostic marker.